BioSpace News Archive

Incyte (Nasdaq:INCY) and MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR) today announced that the companies intend to host a conference call and webcast to discuss global development, unmet need and commercial opportunities for tafasitamab.

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today highlighted data from the Phase 1b portion of the MISSION study demonstrating safety, tolerability and early efficacy signals of KZR-616 in patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) at the Pan-American Congress of Rheumatology (PANLAR 2020)

Equillium, Inc. (Nasdaq: EQ), today announced that data supporting the CD6-ALCAM pathway as a relevant target for therapeutic intervention in patients with uncontrolled asthma was presented in an oral presentation and two posters at the virtual European Respiratory Society (ERS) International Congress 2020 held September 7-9, 2020.

Phibro Animal Health Corporation announced that Richard Johnson, Phibro’s Chief Financial Officer, has informed the Company that he will retire from his position effective November 15, 2020, subsequent to the Company’s annual meeting and completion of the Company’s earnings report for the quarter ending September 30, 2020.

Precision Optics Corporation, Inc. announced that it has scheduled a conference call to discuss fourth quarter and fiscal year 2020 financial results on Thursday, September 24, 2020 at 5:00pm ET.

Geron Corporation reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company.